8 Einträge gefunden

1. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederic
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem der UHH
2. Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

   1. Leyh-Bannurah, Sami-Ramzi
   2. Hansen, Jens
   3. Isbarn, Hendrik
   4. Steuber, Thomas
   5. Tennstedt, Pierre
   6. Michl, Uwe
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
3. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

   1. Flammiger, Anna
   2. Weisbach, Lars
   3. Huland, Hartwig
   4. Tennstedt, Pierre
   5. Simon, Ronald
   6. Minner, Sarah
   7. Bokemeyer, Carsten

   2013 - Forschungsinformationssystem des UKE
4. MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.

   1. Steurer, Stefan
   2. Borkowski, Carina
   3. Odinga, Sinje
   4. Buchholz, Malte
   5. Koop, Christina
   6. Huland, Hartwig
   7. Becker, Michael

   2013 - Forschungsinformationssystem des UKE
5. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE
6. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
7. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.

   1. Hansen, Jens
   2. Auprich, Marco
   3. Ahyai, Sascha A
   4. de la Taille, Alexandre
   5. van Poppel, Hendrik
   6. Marberger, Michael
   7. Stenzl, Arnulf

   2013 - Forschungsinformationssystem des UKE
8. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederik
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem des UKE